Cover ImageSALE
市場調查報告書

微生物定序服務的全球市場:2018年∼2022年

Global Microbiome Sequencing Services Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 605149
出版日期 內容資訊 英文 112 Pages
訂單完成後即時交付
價格
Back to Top
微生物定序服務的全球市場:2018年∼2022年 Global Microbiome Sequencing Services Market 2018-2022
出版日期: 2018年02月14日 內容資訊: 英文 112 Pages
簡介

關於微生物定序服務

微生物定序,人體表現出來的微生物群分析,有助於調查疾病的診斷的影響。

Technavio的分析師預測,從2018年到2022年期間,22.10%的年複合成長率全球微生物定序服務市場將以成長。

本報告提供全球微生物定序服務市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模與預測

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第7章 客戶形勢

第8章 市場區隔:各終端用戶

  • 概要
  • 比較:各終端用戶
  • 製藥公司/生物科技企業
  • 學術機構/研究機關
  • 其他
  • 市場機會:各終端用戶

第9章 地區形勢

  • 概要
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 對癌症的增生和治療中的微生物的意識高漲
  • 準確度高的鑑識工具的需求高漲
  • 在臨床工作流程的微生物定序的採用增加

第13章 業者情勢

  • 概要
  • 創造性破壞

第14章 供應商分析

  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • BGI
  • Clinical-Microbiomics
  • Diversigen
  • GATC Biotech
  • Second Genome
  • 其他有力的供應商

第15章 附錄

  • 簡稱清單
目錄
Product Code: IRTNTR20677

About Microbiome Sequencing Services

Microbiome sequencing helps in analyzing microbial communities found in the human body and finding their impact on disease diagnosis.

Technavio's analysts forecast the global microbiome sequencing services market to grow at a CAGR of 22.10% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global microbiome sequencing services market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Microbiome Sequencing Services Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • BGI
  • Clinical-Microbiomics
  • Diversigen
  • GATC Biotech
  • Second Genome

Market driver

  • Rise in chronic and infectious diseases
  • For a full, detailed list, view our report

Market challenge

  • High cost of sequencing systems
  • For a full, detailed list, view our report

Market trend

  • Growing awareness of microbiome in cancer development and therapy
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Overview
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies
  • Academic institutes and research laboratories
  • Others
  • Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

  • Overview
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Growing awareness of microbiome in cancer development and therapy
  • Growing demand for highly accurate forensic tools
  • Increasing adoption of microbiome sequencing in clinical workflows

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • BGI
  • Clinical-Microbiomics
  • Diversigen
  • GATC Biotech
  • Second Genome
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Related market
  • Exhibit 02: Market characteristics
  • Exhibit 03: Market segments
  • Exhibit 04: Market definition - Inclusions and exclusions checklist
  • Exhibit 05: Market size 2017
  • Exhibit 06: Validation techniques employed for market sizing 2017
  • Exhibit 07: Global microbiome sequencing services market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 08: Global microbiome sequencing services market - Year over year growth 2018-2022 (%)
  • Exhibit 09: Five forces analysis 2017
  • Exhibit 10: Five forces analysis 2022
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2017
  • Exhibit 17: Market condition: Five forces 2022
  • Exhibit 18: Customer landscape
  • Exhibit 19: End-user - Market share 2017-2022 (%)
  • Exhibit 20: Comparison by end-user
  • Exhibit 21: Pharmaceutical and biotechnology companies - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 22: Pharmaceutical and biotechnology companies - Year over year growth 2018-2022 (%)
  • Exhibit 23: Academic institutes and research laboratories - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 24: Academic institutes and research laboratories - Year over year growth 2018-2022 (%)
  • Exhibit 25: Others - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 26: Others - Year over year growth 2018-2022 (%)
  • Exhibit 27: Market opportunity by end-user
  • Exhibit 28: Global - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Americas - Year over year growth 2018-2022 (%)
  • Exhibit 32: Top 3 countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 35: Top 3 countries in EMEA
  • Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: APAC - Year over year growth 2018-2022 (%)
  • Exhibit 38: Top 3 countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: R&D funding in $ millions for malaria from 2013-2016
  • Exhibit 41: R&D funding in $ millions for HIV from 2013-2016
  • Exhibit 42: Cost of sequencing per genome in $ (2001-2015)
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: BGI: Overview
  • Exhibit 49: BGI: Business segments
  • Exhibit 50: BGI: Organizational developments
  • Exhibit 51: BGI: Geographic focus
  • Exhibit 52: BGI: Segment focus
  • Exhibit 53: BGI: Key offerings
  • Exhibit 54: Clinical-Microbiomics: Overview
  • Exhibit 55: Clinical-Microbiomics: Business segments
  • Exhibit 56: Clinical-Microbiomics: Organizational developments
  • Exhibit 58: Clinical-Microbiomics: Geographic focus
  • Exhibit 59: Clinical-Microbiomics: Segment focus
  • Exhibit 60: Clinical-Microbiomics: Key offerings
  • Exhibit 61: Diversigen: Overview
  • Exhibit 62: Diversigen - Business segments
  • Exhibit 63: Diversigen - Organizational developments
  • Exhibit 64: Diversigen - Geographic focus
  • Exhibit 65: Diversigen - Segment focus
  • Exhibit 66: Diversigen - Key offerings
  • Exhibit 67: GATC Biotech: Overview
  • Exhibit 68: GATC Biotech: Business segments
  • Exhibit 69: GATC Biotech: Organizational developments
  • Exhibit 70: GATC Biotech: Geographic focus
  • Exhibit 71: GATC Biotech: Segment focus
  • Exhibit 72: GATC Biotech - Key offerings
  • Exhibit 73: Second Genome: Overview
  • Exhibit 74: Second Genome - Business segments
  • Exhibit 75: Second Genome - Organizational developments
  • Exhibit 76: Second Genome - Geographic focus
  • Exhibit 77: Second Genome - Segment focus
  • Exhibit 78: Second Genome - Key offering
Back to Top